Overview
Merck & Co., Inc., based in the United States, is a prominent global healthcare company that primarily operates in the pharmaceutical industry. The company is dedicated to the discovery, development, manufacture, and marketing of a wide range of innovative health solutions. Its portfolio includes prescription medicines, vaccines, biologic therapies, and animal health products. Merck & Co., Inc. is engaged in key projects that focus on oncology, infectious diseases, and vaccines, reflecting its commitment to addressing some of the most urgent medical challenges. Through its research and development efforts, Merck aims to sustain its leadership in these areas, ensuring continuous improvement in healthcare outcomes globally.
AI+ Ask Fintel’s AI assistant about Merck & Co., Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Merck & Co., Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 2,513.00 MM |
| Earnings Date | |
| EPS (TTM) | 6.53 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-09-15 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.15 |
| ROE | 0.41 |
| ROIC | 0.20 |
| CROIC | -0.04 |
| OCROIC | 0.22 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 61.55 /100 |
| Profitability | 67.72 /100 |
| Quality Score | 77.45 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | 18.30 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Merck & Co., Inc. is CLP105,910.28. The forecasts range from a low of CLP84,659.60 to a high of CLP144,379.99. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Merck & Co., Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-18 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-04 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-26 | Truist Securities | Buy | Buy | Maintains |
| 2024-04-18 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-08 | Berenberg | Buy | Buy | Maintains |
| 2024-04-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-03-28 | Truist Securities | Buy | Buy | Reiterate |
| 2024-03-27 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-03-27 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-11 | Societe Generale | Hold | Sell | Downgrade |
| 2024-03-11 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-29 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-14 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-02 | UBS | Buy | Buy | Maintains |
| 2024-02-02 | Truist Securities | Buy | Buy | Maintains |
| 2024-02-02 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-02 | Barclays | Overweight | Overweight | Maintains |
| 2024-01-23 | Barclays | Overweight | Overweight | Maintains |
| 2024-01-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-04 | TD Cowen | Market Perform | Outperform | Upgrade |
| 2023-11-29 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-09 | Deutsche Bank | Buy | Initiate | |
| 2023-10-27 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-27 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2023-10-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-06 | Truist Securities | Buy | Buy | Reiterate |
| 2023-10-04 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-09-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-02 | Truist Securities | Buy | Buy | Maintains |
| 2023-08-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-20 | Truist Securities | Buy | Buy | Maintains |
| 2023-07-14 | HSBC | Hold | Initiate | |
| 2023-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-05-30 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-05-01 | Atlantic Equities | Overweight | Maintains | |
| 2023-05-01 | Barclays | Overweight | Maintains | |
| 2023-04-13 | Citigroup | Neutral | Buy | Upgrade |
| 2023-04-11 | Guggenheim | Buy | Maintains | |
| 2023-04-10 | Mizuho | Buy | Reiterate | |
| 2023-03-17 | Mizuho | Buy | Reiterate | |
| 2023-03-13 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2023-03-10 | Berenberg | Buy | Maintains | |
| 2023-03-07 | Credit Suisse | Outperform | Maintains | |
| 2023-03-07 | Atlantic Equities | Overweight | Maintains | |
| 2023-03-06 | Jefferies | Buy | Initiate | |
| 2023-02-23 | JP Morgan | Overweight | Maintains | |
| 2023-02-22 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2023-02-13 | Credit Suisse | Outperform | Maintains | |
| 2023-02-03 | Wells Fargo | Overweight | Maintains | |
| 2023-02-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-03 | Truist Securities | Buy | Maintains | |
| 2023-02-03 | SVB Leerink | Outperform | Maintains | |
| 2023-01-23 | SVB Leerink | Outperform | Maintains | |
| 2023-01-04 | B of A Securities | Neutral | Buy | Upgrade |
| 2023-01-03 | Wells Fargo | Overweight | Maintains | |
| 2022-12-19 | Cantor Fitzgerald | Overweight | Maintains | |
| 2022-11-18 | Credit Suisse | Outperform | Initiate | |
| 2022-11-01 | Guggenheim | Buy | Maintains | |
| 2022-10-28 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-28 | Barclays | Overweight | Maintains | |
| 2022-10-28 | Truist Securities | Buy | Maintains | |
| 2022-10-28 | Wells Fargo | Overweight | Maintains | |
| 2022-10-28 | SVB Leerink | Outperform | Maintains | |
| 2022-10-28 | Atlantic Equities | Overweight | Maintains | |
| 2022-10-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-11 | Atlantic Equities | Overweight | Maintains | |
| 2022-10-10 | Guggenheim | Neutral | Buy | Upgrade |
| 2022-09-30 | SVB Leerink | Outperform | Maintains | |
| 2022-09-14 | Berenberg | Hold | Buy | Upgrade |
| 2022-09-12 | SVB Leerink | Outperform | Maintains | |
| 2022-08-25 | Erste Group | Hold | Buy | Upgrade |
| 2022-07-29 | Barclays | Overweight | Maintains | |
| 2022-07-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-29 | SVB Leerink | Outperform | Maintains | |
| 2022-07-18 | UBS | Neutral | Maintains | |
| 2022-07-13 | Atlantic Equities | Overweight | Maintains | |
| 2022-07-08 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-07 | Daiwa Capital | Hold | Outperform | Upgrade |
| 2022-06-27 | Cowen & Co. | Market Perform | Maintains | |
| 2022-04-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-29 | Wells Fargo | Overweight | Maintains | |
| 2022-04-29 | SVB Leerink | Outperform | Maintains | |
| 2022-04-21 | SVB Leerink | Outperform | Maintains | |
| 2022-04-12 | Barclays | Overweight | Maintains | |
| 2022-04-06 | SVB Leerink | Outperform | Maintains | |
| 2022-04-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-02-04 | SVB Leerink | Outperform | Maintains | |
| 2022-01-28 | JP Morgan | Overweight | Maintains | |
| 2021-12-16 | Daiwa Capital | Neutral | Initiate | |
| 2021-12-13 | UBS | Buy | Neutral | Downgrade |
| 2021-12-09 | Wells Fargo | Overweight | Initiate | |
| 2021-12-07 | Guggenheim | Buy | Neutral | Downgrade |
| 2021-11-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-11-29 | Citigroup | Buy | Neutral | Downgrade |
| 2021-11-19 | BMO Capital | Market Perform | Initiate | |
| 2021-11-01 | Barclays | Overweight | Maintains | |
| 2021-11-01 | Argus Research | Hold | Buy | Upgrade |
| 2021-10-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-22 | SVB Leerink | Outperform | Maintains | |
| 2021-10-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-11 | Berenberg | Hold | Maintains | |
| 2021-10-08 | Barclays | Overweight | Maintains | |
| 2021-10-04 | SVB Leerink | Outperform | Maintains | |
| 2021-09-07 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2021-07-30 | SVB Leerink | Outperform | Maintains | |
| 2021-06-09 | JP Morgan | Overweight | Maintains | |
| 2021-06-07 | Truist Securities | Buy | Maintains | |
| 2021-06-03 | SVB Leerink | Outperform | Maintains | |
| 2021-05-20 | Argus Research | Buy | Hold | Downgrade |
| 2021-04-30 | SVB Leerink | Outperform | Maintains | |
| 2020-11-10 | Bernstein | Outperform | Reiterate | |
| 2020-10-29 | SVB Leerink | Outperform | Maintains | |
| 2020-10-23 | Truist Securities | Buy | Initiate | |
| 2020-10-16 | JP Morgan | Overweight | Maintains | |
| 2020-09-29 | Berenberg | Hold | Initiate | |
| 2020-08-25 | SVB Leerink | Outperform | Maintains | |
| 2020-08-03 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2020-06-12 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2020-04-29 | Barclays | Overweight | Maintains | |
| 2020-04-29 | Guggenheim | Buy | Maintains | |
| 2020-04-29 | SVB Leerink | Outperform | Maintains | |
| 2020-04-13 | UBS | Buy | Maintains | |
| 2020-04-02 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-01 | RBC Capital | Sector Perform | Maintains | |
| 2020-03-24 | Argus Research | Buy | Maintains | |
| 2020-02-06 | UBS | Buy | Maintains | |
| 2020-01-23 | UBS | Buy | Maintains | |
| 2019-11-13 | Morgan Stanley | Overweight | Maintains | |
| 2019-08-16 | SVB Leerink | Outperform | Initiate | |
| 2019-07-03 | Mizuho | Buy | Initiate | |
| 2019-06-21 | Morgan Stanley | Overweight | Maintains | |
| 2019-06-14 | JP Morgan | Overweight | Maintains | |
| 2019-05-28 | Goldman Sachs | Neutral | Initiate | |
| 2019-05-02 | UBS | Buy | Buy | Maintains |
| 2019-05-01 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2019-05-01 | Bank of America | Buy | Buy | Maintains |
| 2019-02-22 | Cantor Fitzgerald | Overweight | Initiate | |
| 2019-01-23 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2018-11-01 | Citigroup | Buy | Buy | Maintains |
| 2018-10-31 | Citigroup | Buy | Buy | Maintains |
| 2018-10-29 | SunTrust Robinson Humphrey | Buy | Buy | Maintains |
| 2018-10-26 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-10-22 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-10-16 | Citigroup | Buy | Buy | Maintains |
| 2018-10-12 | Barclays | Overweight | Overweight | Maintains |
| 2018-10-11 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-09-07 | Barclays | Overweight | Overweight | Maintains |
| 2018-08-23 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-30 | Bank of America | Buy | Buy | Maintains |
| 2018-04-26 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-04-23 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2018-04-18 | Bank of America | Buy | Buy | Maintains |
| 2018-04-17 | Bank of America | Buy | Buy | Maintains |
| 2018-04-17 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2018-04-05 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2018-02-14 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-02-14 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-02-13 | DZ Bank | Hold | Buy | Upgrade |
| 2018-02-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-02-06 | Leerink Swann | Market Perform | Market Perform | Maintains |
| 2018-02-05 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-01-16 | SunTrust Robinson Humphrey | Hold | Buy | Upgrade |
| 2017-10-31 | BMO Capital | Outperform | Maintains | |
| 2017-10-31 | Jefferies | Underperform | Hold | Upgrade |
| 2017-10-30 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2017-10-30 | UBS | Buy | Maintains | |
| 2017-10-30 | SunTrust Robinson Humphrey | Buy | Hold | Downgrade |
| 2017-10-30 | Leerink Swann | Market Perform | Maintains | |
| 2017-10-30 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2017-10-23 | Leerink Swann | Market Perform | Maintains | |
| 2017-10-18 | Citigroup | Neutral | Buy | Upgrade |
| 2017-10-12 | BMO Capital | Outperform | Maintains | |
| 2017-09-08 | Credit Suisse | Outperform | Maintains | |
| 2017-08-30 | Credit Suisse | Outperform | Maintains | |
| 2017-07-31 | UBS | Buy | Maintains | |
| 2017-07-17 | Deutsche Bank | Hold | Maintains | |
| 2017-01-12 | Guggenheim | Neutral | Buy | Upgrade |
| 2017-01-12 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2016-12-19 | Jefferies | Hold | Underperform | Downgrade |
| 2016-10-13 | Bank of America | Neutral | Buy | Upgrade |
| 2016-09-12 | Jefferies | Hold | Maintains | |
| 2016-09-09 | Barclays | Overweight | Maintains | |
| 2016-08-19 | UBS | Buy | Maintains | |
| 2016-08-08 | Jefferies | Hold | Maintains | |
| 2016-08-08 | Deutsche Bank | Hold | Maintains | |
| 2016-08-07 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2016-08-05 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2016-07-18 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2016-07-14 | Jefferies | Hold | Maintains | |
| 2016-06-14 | Jefferies | Hold | Maintains | |
| 2016-05-09 | Credit Suisse | Neutral | Maintains | |
| 2016-04-15 | Jefferies | Hold | Maintains | |
| 2016-04-06 | Societe Generale | Buy | Initiate | |
| 2016-03-15 | Jefferies | Hold | Maintains | |
| 2016-01-27 | Bank of America | Buy | Neutral | Downgrade |
| 2016-01-14 | Jefferies | Hold | Maintains | |
| 2015-12-01 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2015-11-24 | Berenberg | Buy | Initiate | |
| 2015-09-21 | JP Morgan | Overweight | Maintains | |
| 2015-08-27 | Jefferies | Hold | Maintains | |
| 2015-08-13 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2015-06-17 | PiperJaffray | Neutral | Initiate | |
| 2015-05-21 | Jefferies | Hold | Maintains | |
| 2015-04-29 | Deutsche Bank | Hold | Maintains | |
| 2015-03-16 | Leerink Swann | Market Perform | Maintains | |
| 2015-03-10 | Jefferies | Hold | Maintains | |
| 2015-02-20 | Jefferies | Hold | Maintains | |
| 2015-01-22 | Deutsche Bank | Hold | Maintains | |
| 2015-01-16 | Barclays | Underweight | Equal-weight | Upgrade |
| 2015-01-15 | Jefferies | Hold | Maintains | |
| 2015-01-05 | Bernstein | Market Perform | Outperform | Upgrade |
| 2014-12-04 | Jefferies | Hold | Maintains | |
| 2014-11-18 | Jefferies | Hold | Maintains | |
| 2014-10-13 | Jefferies | Hold | Maintains | |
| 2014-10-02 | Guggenheim | Neutral | Initiate | |
| 2014-09-15 | Jefferies | Hold | Maintains | |
| 2014-08-27 | Deutsche Bank | Hold | Initiate | |
| 2014-08-11 | Jefferies | Hold | Maintains | |
| 2014-07-31 | Credit Suisse | Neutral | Maintains | |
| 2014-07-28 | Mainfirst | Underperform | Outperform | Upgrade |
| 2014-07-08 | Citigroup | Neutral | Maintains | |
| 2014-07-07 | Citigroup | Neutral | Maintains | |
| 2014-07-02 | Barclays | Equal-Weight | Maintains | |
| 2014-05-08 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2014-05-08 | Credit Suisse | Neutral | Maintains | |
| 2014-05-07 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2014-05-07 | JP Morgan | Overweight | Maintains | |
| 2014-04-30 | UBS | Buy | Maintains | |
| 2014-04-28 | Credit Suisse | Outperform | Maintains | |
| 2014-04-24 | Bank of America | Buy | Maintains | |
| 2014-04-14 | Jefferies | Hold | Maintains | |
| 2014-04-14 | MKM Partners | Buy | Maintains | |
| 2014-02-04 | SunTrust Robinson Humphrey | Neutral | Buy | Upgrade |
| 2014-01-27 | Morgan Stanley | Underweight | Overweight | Upgrade |
| 2013-10-14 | Bernstein | Outperform | Market Perform | Downgrade |
| 2013-10-14 | Barclays | Overweight | Equal-weight | Downgrade |
| 2013-10-11 | Jefferies | Buy | Hold | Downgrade |
| 2013-10-08 | Credit Suisse | Neutral | Initiate | |
| 2013-07-18 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2013-07-12 | Jefferies | Buy | Maintains | |
| 2013-06-24 | BMO Capital | Outperform | Maintains | |
| 2013-06-07 | Jefferies | Buy | Maintains | |
| 2013-05-29 | SunTrust Robinson Humphrey | Neutral | Initiate | |
| 2013-05-28 | Jefferies | Hold | Buy | Upgrade |
| 2013-04-19 | BMO Capital | Outperform | Maintains | |
| 2013-04-10 | Jefferies | Hold | Maintains | |
| 2013-03-04 | Bank of America | Neutral | Buy | Upgrade |
| 2013-02-25 | Jefferies | Hold | Maintains | |
| 2013-02-15 | BMO Capital | Outperform | Maintains | |
| 2013-02-04 | BMO Capital | Outperform | Maintains | |
| 2013-02-04 | Barclays | Overweight | Maintains | |
| 2013-02-04 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2013-02-04 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2013-01-16 | Jefferies | Hold | Maintains | |
| 2012-12-20 | Goldman Sachs | Neutral | Maintains | |
| 2012-11-30 | Citigroup | Neutral | Initiate | |
| 2012-11-20 | MKM Partners | Neutral | Buy | Upgrade |
| 2012-11-12 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2012-10-29 | BMO Capital | Market Perform | Maintains | |
| 2012-10-15 | Barclays | Overweight | Maintains | |
| 2012-10-12 | Jefferies | Hold | Maintains | |
| 2012-08-24 | Bank of America | Buy | Neutral | Downgrade |
| 2012-08-13 | Jefferies | Hold | Maintains | |
| 2012-08-09 | Credit Suisse | Outperform | Maintains | |
| 2012-07-30 | UBS | Buy | Maintains | |
| 2012-07-30 | BMO Capital | Market Perform | Maintains | |
| 2012-07-18 | Morgan Stanley | Equal-Weight | Maintains | |
| 2012-07-13 | Jefferies | Hold | Maintains | |
| 2012-07-12 | Citigroup | Neutral | Buy | Upgrade |
| 2012-07-12 | Goldman Sachs | Neutral | Maintains | |
| 2012-07-10 | Deutsche Bank | Buy | Maintains | |
| 2012-05-18 | BMO Capital | Market Perform | Initiate | |
| 2025-04-17 | Guggenheim | Buy | Buy | Reiterate |
| 2025-01-13 | Leerink Partners | Outperform | Outperform | Maintains |
| 2025-04-22 | Cantor Fitzgerald | Neutral | Initiate | |
| 2025-01-08 | UBS | Buy | Buy | Maintains |
| 2025-01-08 | Truist Securities | Buy | Hold | Downgrade |
| 2024-08-29 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-31 | UBS | Buy | Buy | Maintains |
| 2024-07-31 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-31 | B of A Securities | Buy | Buy | Maintains |
| 2024-07-31 | Barclays | Overweight | Overweight | Maintains |
| 2024-11-07 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-03 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-11-01 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-11-01 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-28 | Citigroup | Buy | Buy | Maintains |
| 2024-11-06 | Guggenheim | Buy | Buy | Maintains |
| 2024-09-16 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-25 | Citigroup | Buy | Buy | Maintains |
| 2024-10-07 | Barclays | Overweight | Overweight | Maintains |
| 2024-11-15 | Wolfe Research | Peer Perform | Initiate | |
| 2025-02-05 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2025-02-05 | B of A Securities | Buy | Buy | Maintains |
| 2025-02-05 | Citigroup | Buy | Buy | Maintains |
| 2025-02-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-17 | Bernstein | Market Perform | Initiate | |
| 2024-10-09 | Truist Securities | Buy | Buy | Maintains |
| 2025-02-12 | Guggenheim | Buy | Buy | Maintains |
| 2024-12-10 | B of A Securities | Buy | Reiterate | |
| 2025-01-21 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-12-20 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2025-02-18 | Deutsche Bank | Buy | Hold | Downgrade |
| 2024-10-09 | UBS | Buy | Buy | Maintains |
| 2025-05-14 | Citigroup | Buy | Neutral | Downgrade |
| 2025-07-30 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-10 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
